Copyright © 1993 by the European Society of Cardiology.
© 1993 The Europen Society of Cardiology
Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling
Division of Cardiology, Department of Medicine, Östra Hospital Göteborg, Sweden
Received 11 December 1992; revised 25 February 1993; .
Correspondence. Axel Sigurdsson MD. Division of Cardiology. Department of Medicine, Östra Hospital, 41685 Göteborg, Sweden
Abstract
Plasma neurohormones were sequentially analysed in 98 patients with acute myocardial infarction randomized to treatment with enalapril or placebo for 46 months. Plasma angiotensin converting enzyme activity was rapidly suppressed by enalapril, but unaffected by placebo (P = 0.0001). No significant differences were found in the plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide, noradrenaline, adrenaline or dopamine between the two treatment groups. Among patients with infarct size above median, plasma angiotensin II increased during head-up tilt at one month in the placebo group, but not in the enalapril group. Left ventricular end-diastolic volume (LVEDV) and left ventricular endsystolic volume (LVESV) were evaluated by echocardiography in 28 patients (placebo 15, enalapril 13) and changes in left ventricular volumes between baseline and 46 months were calculated. Only in the placebo group was a positive correlation found between plasma levels of noradrenaline at day 57 and the subsequent increase in LVEDV (r = 0.78, P = 0.005) and LVESV (r = 0.75, P = 0.008). The same trend was found for angiotensin II, adrenaline and dopamine levels at days 57 and the subsequent increase in left ventricular volumes. In the placebo group a negative correlation was found between plasma aldosterone at days 57 and the subsequent increase in left ventricular ejection fraction (r = 0.77, P = 0.006) during the study period. Although circulating neurohormones were not significantly influenced by enalapril treatment, it is concluded that enalapril may influence the relationship found between sustained neurohormonal activation and left ventricular remodelling after acute myocardial infarction.
Key Words: Acute myocardial infarction neurohormonal activation enalapril angiotensin converting enzyme inhibitors left ventricular remodelling
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. N. Nanas, G. Alexopoulos, M. I. Anastasiou-Nana, K. Karidis, A. Tirologos, S. Zobolos, V. Pirgakis, L. Anthopoulos, D. Sideris, S. F. Stamatelopoulos, et al. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2090 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Jugdutt, M. I. Khan, S. J. Jugdutt, and G. E. Blinston Effect of Enalapril on Ventricular Remodeling and Function During Healing After Anterior Myocardial Infarction in the Dog Circulation, February 1, 1995; 91(3): 802 - 812. [Abstract] [Full Text] |
||||

